RNA Interference: Biology, Mechanism, and Applications
Open accessThe DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Abstract
SUMMARY: Double-stranded RNA-mediated interference (RNAi) is a simple and rapid method of silencing gene expression in a range of organisms. The silencing of a gene is a consequence of degradation of RNA into short RNAs that activate ribonucleases to target homologous mRNA. The resulting phenotypes either are identical to those of genetic null mutants or resemble an allelic series of mutants. Specific gene silencing has been shown to be related to two ancient processes, cosuppression in plants and quelling in fungi, and has also been associated with regulatory processes such as transposon silencing, antiviral defense mechanisms, gene regulation, and chromosomal modification. Extensive genetic and biochemical analysis revealed a two-step mechanism of RNAi-induced gene silencing. The first step involves degradation of dsRNA into small interfering RNAs (siRNAs), 21 to 25 nucleotides long, by an RNase III-like activity. In the second step, the siRNAs join an RNase complex, RISC (RNA-induced silencing complex), which acts on the cognate mRNA and degrades it. Several key components such as Dicer, RNA-dependent RNA polymerase, helicases, and dsRNA endonucleases have been identified in different organisms for their roles in RNAi. Some of these components also control the development of many organisms by processing many noncoding RNAs, called micro-RNAs. The biogenesis and function of micro-RNAs resemble RNAi activities to a large extent. Recent studies indicate that in the context of RNAi, the genome also undergoes alterations in the form of DNA methylation, heterochromatin formation, and programmed DNA elimination. As a result of these changes, the silencing effect of gene functions is exercised as tightly as possible. Because of its exquisite specificity and efficiency, RNAi is being considered as an important tool not only for functional genomics, but also for gene-specific therapeutic activities that target the mRNAs of disease-related genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Viral pathogenicity determinants are suppressors of transgene silencing in Nicotiana benthamiana
Brigneti, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6739 · Cited by 1,067
RetractedPotent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948 · cited 1×
“elegans which was arrested at the first larval stage (127).”
BackgroundDuplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111 · cited 1×
“Detailed deletion and expression analyses point out that these two micro-RNAs are located within a 30-kb region of loss in chronic lymphocytic leukemias, and both genes are deleted or downregulated in a majority ( 68%) of chronic lymphocytic leukemia cases (30).”
Identification of Novel Genes Coding for Small Expressed RNAs
Lagos-Quintana, M., Rauhut, R., Lendeckel, W., & Tuschl, T. (2001) · Science · doi:10.1126/science.1064921 · Cited by 4,956 · cited 2×
“melanogaster (123, 125) and in the inflorescence tissues of A.”
BackgroundRole for a bidentate ribonuclease in the initiation step of RNA interference
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 4,892
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
Mathews, D. H., Sabina, J., Zuker, M., & Turner, D. H. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2700 · Cited by 3,795 · cited 1×
“With the RNA folding program mfold (148) and Northern analyses of micro-RNA, it has been universally inferred that most microRNAs arise from the imperfectly annealed 70-nucleotide hairpin precursor RNA whose expression is often developmentally regulated.”
BackgroundSystematic functional analysis of the Caenorhabditis elegans genome using RNAi
Kamath, R. S., Fraser, A. G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., Le Bot, N., Moreno, S., Sohrmann, M., et al. (2003) · Nature · doi:10.1038/nature01278 · Cited by 3,616
Cited by
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
Burslem, G. M., & Crews, C. M. (2020) · Cell · doi:10.1016/j.cell.2019.11.031 · Cited by 1,079
“The use of RNA interference has become ubiquitous in modern biological research and represents an excellent tool to study protein function (Agrawal et al., 2003; Setten et al., 2019).”
The One Health Concept: 10 Years Old and a Long Road Ahead
Destoumieux-Garzón, D., Mavingui, P., Boetsch, G., Boissier, J., Darriet, F., Duboz, P., Fritsch, C., Giraudoux, P., Le Roux, F., Morand, S., et al. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00014 · Cited by 992
RNAi-Mediated Chromatin Silencing in Fission Yeast
White, S. A., & Allshire, R. C. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75157-1_8 · Cited by 971
Mechanisms, Applications, and Challenges of Insect RNA Interference
Zhu, K. Y., & Palli, S. R. (2020) · Annual Review of Entomology · doi:10.1146/annurev-ento-011019-025224 · Cited by 709
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
O’Donoghue, M. L., Rosenson, R. S., Gencer, B., López, J. A. G., Lepor, N. E., Baum, S. J., Stout, E., Gaudet, D., Knusel, B., Kuder, J. F., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2211023 · Cited by 599
Innate immunity of the bovine mammary gland
Rainard, P., & Riollet, C. (2006) · Veterinary Research · doi:10.1051/vetres:2006007 · Cited by 551
Joga, M. R., Zotti, M. J., Smagghe, G., & Christiaens, O. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00553 · Cited by 521
RNA interference technology in crop protection against arthropod pests, pathogens and nematodes
Zotti, M., dos Santos, E. A., Cagliari, D., Christiaens, O., Taning, C. N. T., & Smagghe, G. (2018) · Pest Management Science · doi:10.1002/ps.4813 · Cited by 465
The Ecology and Evolution of Pangenomes
Brockhurst, M. A., Harrison, E., Hall, J. P. J., Richards, T., McNally, A., & MacLean, C. (2019) · Current Biology · doi:10.1016/j.cub.2019.08.012 · Cited by 385
The critical role of RNA processing and degradation in the control of gene expression
Arraiano, C. M., Andrade, J. M., Domingues, S., Guinote, I. B., Malecki, M., Matos, R. G., Moreira, R. N., Pobre, V., Reis, F. P., Saramago, M., et al. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00242.x · Cited by 349
Exosomes Derived from HIV-1-infected Cells Contain Trans-activation Response Element RNA
Narayanan, A., Iordanskiy, S., Das, R., Van Duyne, R., Santos, S., Jaworski, E., Guendel, I., Sampey, G., Dalby, E., Iglesias-Ussel, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438895 · Cited by 316
Overcoming resistance to tumor-targeted and immune-targeted therapies
Aldea, M., Andre, F., Marabelle, A., Dogan, S., Barlesi, F., & Soria, J.-C. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1638 · Cited by 311
Acoustically Propelled Nanomotors for Intracellular siRNA Delivery
Esteban-Fernández de Ávila, B., Angell, C., Soto, F., Lopez-Ramirez, M. A., Báez, D. F., Xie, S., Wang, J., & Chen, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b01415 · Cited by 309
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment
Xu, X., Liu, C., Wang, Y., Koivisto, O., Zhou, J., Shu, Y., & Zhang, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113891 · Cited by 289
Small-Molecule Modulation of Protein Homeostasis
Burslem, G. M., & Crews, C. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00077 · Cited by 283
Management of Pest Insects and Plant Diseases by Non-Transformative RNAi
Cagliari, D., Dias, N. P., Galdeano, D. M., dos Santos, E. Á., Smagghe, G., & Zotti, M. J. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.01319 · Cited by 279
A computational study of off-target effects of RNA interference
Qiu, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki324 · Cited by 274
Application of Aptamers in Virus Detection and Antiviral Therapy
Zou, X., Wu, J., Gu, J., Shen, L., & Mao, L. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01462 · Cited by 259
Human Argonaute 2 Has diverse reaction pathways on Target RNAs
Jo, M. H., Shin, S., Jung, S.-R., Kim, E., Song, J.-J., & Hohng, S. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.027 · Cited by 207
Yang, M., Li, C.-J., Sun, X., Guo, Q., Xiao, Y., Su, T., Tu, M.-L., Peng, H., Lu, Q., Liu, Q., et al. (2017) · Nature Communications · doi:10.1038/ncomms16003 · Cited by 202
RNA Interference and its Role in Cancer Therapy
Mansoori, B., Shotorbani, S. S., & Baradaran, B. (2014) · PubMed · doi:10.5681/apb.2014.046 · Cited by 180
HSP90AB1: Helping the good and the bad
Haase, M., & Fitze, G. (2016) · Gene · doi:10.1016/j.gene.2015.08.063 · Cited by 179
The mitochondrial genome encodes abundant small noncoding RNAs
Ro, S., Ma, H.-Y., Park, C., Ortogero, N., Song, R., Hennig, G. W., Zheng, H., Lin, Y.-M., Moro, L., Hsieh, J.-T., et al. (2013) · Cell Research · doi:10.1038/cr.2013.37 · Cited by 178
Designing Transcription Factor Architectures for Drug Discovery
Blancafort, P., Segal, D. J., & Barbas, C. F. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002758 · Cited by 171
“Use of siRNAs consisting of fewer than 30 nucleotides long is preferred, because these RNAs do not elicit interferon responses in many cell types and organisms (Agrawal et al., 2004).”
BackgroundKumar, M., Gupta, G. P., & Rajam, M. V. (2009) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2008.12.005 · Cited by 169
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system
DeRosa, F., Guild, B., Karve, S., Smith, L., Love, K., Dorkin, J. R., Kauffman, K. J., Zhang, J., Yahalom, B., Anderson, D. G., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.46 · Cited by 159
Long Non-Coding RNAs as Master Regulators in Cardiovascular Diseases
Archer, K., Broskova, Z., Bayoumi, A., Teoh, J.-P., Davila, A., Tang, Y., Su, H., & Kim, I.-M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161023651 · Cited by 159
“SiRNAs comprise of 20–25 base pairs in length and regulate gene expression, mostly through the RNA interference (RNAi) pathway [5].”
BackgroundSerrano-Sevilla, I., Artiga, Á., Mitchell, S. G., De Matteis, L., & de la Fuente, J. M. (2019) · Molecules · doi:10.3390/molecules24142570 · Cited by 148
Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation
Mahas, A., Neal Stewart, C., & Mahfouz, M. M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.11.008 · Cited by 110
Inclisiran: a new promising agent in the management of hypercholesterolemia
Kosmas, C. E., Muñoz Estrella, A., Sourlas, A., Silverio, D., Hilario, E., Montan, P. D., & Guzman, E. (2018) · Diseases · doi:10.3390/diseases6030063 · Cited by 99
Shahzad, R., Jamil, S., Ahmad, S., Nisar, A., Amina, Z., Saleem, S., Zaffar Iqbal, M., Muhammad Atif, R., & Wang, X. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.01.028 · Cited by 88
Nanoparticles and siRNA: a new era in therapeutics?
Pérez-Carrión, M. D., Posadas, I., & Ceña, V. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107102 · Cited by 48
Transcription factors-golden keys to modulate the plant metabolism to develop salinity tolerance
Bhat, B. A., Mir, R. A., Mir, W. R., Hamdani, S. S., & Mir, M. A. (2024) · Plant Stress · doi:10.1016/j.stress.2024.100409 · Cited by 47
Amann, T., Schmieder, V., Faustrup Kildegaard, H., Borth, N., & Andersen, M. R. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27101 · Cited by 46
“These RNA molecules can either bind the mRNA target perfectly resulting in direct mRNA cleavage or with incomplete complementarity leading to translational repression and mRNA degradation (Agrawal et al., 2003).”
Control of postharvest fungal diseases in fruits using external application of RNAi
de Oliveira Filho, J. G., Silva, G. D. C., Cipriano, L., Gomes, M., & Egea, M. B. (2021) · Journal of Food Science · doi:10.1111/1750-3841.15816 · Cited by 37
Naik, S., Shreya, A. B., Raychaudhuri, R., Pandey, A., Lewis, S. A., Hazarika, M., Bhandary, S. V., Rao, B. S. S., & Mutalik, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118712 · Cited by 33
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma
Liu, T., Shen, J. K., Li, Z., Choy, E., Hornicek, F. J., & Duan, Z. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.030 · Cited by 30
Liver organoids: Current advances and future applications for hepatology
Kim, Y., Kang, M., Mamo, M. G., Adisasmita, M., Huch, M., & Choi, D. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.1040 · Cited by 26
Mansoor, T., Rao, B. H., Gupta, K., Parikh, S. S., Abramov, D., Mehta, A., Al Rifai, M., Virani, S. S., Nambi, V., Minhas, A. M. K., et al. (2025) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-024-00712-x · Cited by 12
“In the cytoplasm, double-stranded RNA is cleaved into shorter-length siRNAs by Dicer enzymes followed by binding to Argonaute protein [14, 15].”
Hu, J., Wang, J., Zhang, H., Jiang, Y., Deng, L., Long, E., & Liu, S. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1758366 · Cited by 3
“Moreover, RISC can repeatedly engage new mRNA molecules, conferring prolonged pharmacologic activity to siRNAs (38).”
Epigenetic and experimental approaches influencing non-coding RNAs
(2025) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2025.05.001 · Cited by 3
CoCoNuTs are a diverse subclass of Type IV restriction systems predicted to target RNA
Bell, R. T., Sahakyan, H., Makarova, K. S., Wolf, Y. I., & Koonin, E. V. (2024) · eLife · doi:10.7554/elife.94800.3 · Cited by 3
Wu, A.-X., Wang, X.-J., Zhao, C., Hu, J.-Q., Li, J.-W., Xu, Y., Li, Y., & Liu, S. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108178 · Cited by 2
CoCoNuTs: A diverse subclass of Type IV restriction systems predicted to target RNA
Bell, R. T., Sahakyan, H., Makarova, K. S., Wolf, Y. I., & Koonin, E. V. (2023) · doi:10.1101/2023.07.31.551357 · Cited by 1
CoCoNuTs: A diverse subclass of Type IV restriction systems predicted to target RNA
Bell, R. T., Sahakyan, H., Makarova, K. S., Wolf, Y. I., & Koonin, E. V. (2024) · doi:10.7554/elife.94800.2
Metadata
- Authors
- Agrawal, N., Dasaradhi, P. V. N., Mohmmed, A., Malhotra, P., Bhatnagar, R. K., & Mukherjee, S. K.
- Venue
- Microbiology and Molecular Biology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2003-12
- Volume
- 67
- Issue
- 4
- Pages
- 657-685
- ISSN
- 1092-2172 (ISSN-L)
- 1098-5557
- OpenAlex
- W2146138017
- Cited by
- 1,305
- References
- 221
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.